国家科技部，上海市科委等相关部门，盖茨基金会，上海科技大学等高校，帕斯适宜卫生科技组织 （PATH）等国际组织代表出席启动仪式。 责编：财经-李芳、李雪钦 骆大进在启动仪式上致辞 研究院由上海市生物医药科技产业促进中心和上海交通大学医学院发起成立，是中国首家以全球健 康为使命的新型研发转化机构。研究院将发挥其非营利组织的独特定位，面向中低收入国家，聚焦结核 病、疟疾等传染病，以及妇女儿童健康等重要问题，向全球合作伙伴提供技术支持和资源支撑，促进创 新成果研发转化并加快进入国际市场，为提升中低收入国家健康福祉、促进全球健康公平贡献力量。研 究院首期五年研发经费由上海市和盖茨基金会共同提供，其中盖茨基金会提供项目赠款和技术支持，上 海市提供相应经费和资源。 2025年9月22日，在2025浦江创新论坛全球健康与发展分论坛上，上海全球健康创新研究院 （Global Health Innovation Institute，简称"GHII"，下称"研究院"）宣布正式启动。上海市科学技术委员 会主任骆大进出席仪式并致辞。现场还进行了研究院的理事会、监事会以及核心领导团队的聘任环节。 首任院长由知名专家何如意博士担任。 骆 ...

Core Viewpoint - The article analyzes the financial performance of three companies in the lithium battery industry: EVE Energy, Guoxuan High-Tech, and Sunwoda, highlighting their revenue similarities but significant differences in net profit due to variations in profitability, cost control, business structure, and asset efficiency [1]. Group 1: Revenue and Profit Comparison - EVE Energy reported a revenue of 486.15 billion CNY, a slight decrease of 0.35%, with a net profit of 40.76 billion CNY, down 0.63% [1]. - Guoxuan High-Tech achieved a revenue of 353.92 billion CNY, an increase of 11.98%, but its net profit fell by 28.56% to 12.07 billion CNY [1]. - Sunwoda had the highest revenue at 560.21 billion CNY, up 17.05%, but its net profit decreased by 36.43% to 14.68 billion CNY [1]. Group 2: Gross Margin and Product Structure - EVE Energy excels in high-margin businesses, focusing on large cylindrical batteries and energy storage cells, with a gross margin of 28.87% for energy storage systems, up 7.55 percentage points year-on-year [2]. - Guoxuan High-Tech's business structure is dominated by power batteries (73% of revenue), with energy storage growing but starting from a low base, resulting in a gross margin of only 23.87% [3]. - Sunwoda's consumer battery segment, which constitutes 54% of its revenue, suffers from low margins (10%-15%) due to intense competition, while its power battery segment has not yet realized profitability [4]. Group 3: R&D and Management Efficiency - EVE Energy invests approximately 35 billion CNY in R&D, accounting for 7.2% of its revenue, with a high average salary for R&D staff, leading to efficient conversion of research outcomes into high-margin products [5]. - Guoxuan High-Tech faces increased management costs due to overseas expansion, with a 25% rise in management expenses and a financial cost rate of 3.5%, impacting profitability [5]. - Sunwoda's R&D spending exceeds 40 billion CNY (7.1% of revenue), but its dispersed business model dilutes R&D effectiveness, resulting in a lack of competitive advantage [5]. Group 4: Scale Effect and Per Capita Efficiency - EVE Energy achieves a per capita profit of 140,000 CNY, significantly higher than Guoxuan High-Tech's 46,000 CNY and Sunwoda's 27,000 CNY, due to efficient production and lower costs [6]. - EVE Energy's effective production capacity is 100 GWh with a utilization rate of 70%, while Guoxuan High-Tech has 60 GWh (55% utilization) and Sunwoda 50 GWh (50% utilization), highlighting the impact of scale on fixed cost distribution [6]. - The differences in net profit among the companies are primarily driven by high-margin business focus, cost control, and asset efficiency [6].

同时，公司抛出每10股派38元的历史最高分红方案，派现接近2024年归母净利润的60%，大手笔分红彰 显了公司持续盈利的信心。 财报显示，2024年公司经营活动现金流净额达19.27亿元，净现比接近1:1，这也使公司现金流常年覆盖 分红。 "嗨体"销售突破2000万支 从收入结构看，爱美客核心产品持续稳步增长。"嗨体"作为颈纹修复领域的"国民单品"累计销售超过 2000万只，助推溶液类产品再创新高，2024年实现营收17.44亿元，同比增长4.4%；而在同质化显现的 透明质酸钠凝胶赛道，爱美客凭借再生类产品突出重围，"双生天使"引领面部年轻化市场的"新趋势"， 2024年公司凝胶类产品营收12.16亿元，同比增长5.01%。 爱美客的费用管控能力持续优化，2024年管理费用同比下降14.86%；而销售费用率仅为9.15%，显著低 于行业平均水平，品牌价值驱动效应显著。这再次印证了爱美客的增长逻辑，实现了从"成本控 制"到"价值创造"的质变，为产品研发和品牌建设释放了更多资源。 研发投入持续加码 医美市场的核心竞争力主要是产品落地的能力，辅以精细化的渠道运营体系。爱美客的爆品打造能力 从"嗨体""濡白天使"等明 ...